VaccinesVaccines and corporate profits — where does health end and business begin?
Sources: 11 · Article: 9 290 characters
Jerzy Jaśkowski presents legal immunity as a shield for profits, while Jerzy Zięba alleges that sales take priority over safety rules.
- The STOP NOP Association describes a law adopted after industry lobbying to protect companies and doctors from civil liability.
- Jerzy Zięba alleges that the pharmaceutical industry limits the period during which complications are considered vaccine-related.
What the authors write
Jerzy Zięba
According to Jerzy Zięba, vaccine sales take priority over following the rules and reporting adverse effects.
„No one cares about any rules of the game anymore, as long as vaccines are sold. No one cares that doctors very often fail to report adverse vaccine reactions. In other words, if something happens to a child, they will do everything they can to prove that the vaccine was not to blame.”Nie obchodzą już nikogo żadne reguły gry, byle by tylko szczepionki sprzedać. Nikogo nie obchodzi, że lekarze bardzo często nie zgłaszają niepożądanych odczynów poszczepiennych. Innymi słowy, jeśli dziecku coś się stanie, to na „zębach stają”, żeby wykazać, że nie jest to wina szczepionki.
Jerzy Jaśkowski
Jerzy Jaśkowski presents the vaccine industry's legal immunity as protection for its huge profits from court rulings.
„If vaccines have been thoroughly tested, why does the vaccine industry have legal immunity that exempts it from paying for harm caused by vaccine complications? Compensation in the US currently reaches millions of dollars. In other words, this is the last line of defence for vaccine fanatics against losing the enormous profits they make at the expense of a society they have misled and through fear of court rulings.”Jeżeli szczepionki, zostały dokładnie przebadane, to dlaczego przemysł szczepionkarski ma immunitet prawny zwalniający go od pokrywania szkód powikłań poszczepiennych? Obecnie w USA odszkodowania sięgają milionów dolarów. Czyli, jest to ostania linia obrony fanatyków szczepień przed utratą olbrzymich zysków, otrzymywanych kosztem ogłupianego społeczeństwa i strachu przed wyrokami sądowymi.
Stowarzyszenie STOP NOP
The law was adopted after lobbying by the pharmaceutical industry and medical associations to protect companies and doctors from civil liability.
„The United States Congress passed the National Childhood Vaccine Injury Act.25 Congress created this law in response to lobbying by the pharmaceutical industry and medical associations, with the aim of protecting pharmaceutical companies and doctors from product liability and malpractice lawsuits over complications and deaths resulting from federally and state-recommended and mandatory vaccinations.”Kongres Stanów Zjednoczonych przyjął Krajową Ustawę o Uszkodzeniach Poszczepiennych Dzieci.25 Ustawa ta została utworzona przez Kongres w odpowiedzi na lobbing przemysłu farmaceutycznego i stowarzyszeń medycznych w celu ochrony koncernów farmaceutycznych i lekarzy przed odpowiedzialnością cywilną za produkt oraz sprawy sądowe o błędy w sztuce z powodu powikłań i śmierci w wyniku zalecanych i obowiązkowych szczepień federalnych i stanowych.
Jerzy Zięba
Jerzy Zięba alleges that the pharmaceutical industry considers only complications occurring within the first four weeks to be vaccine-related.
„That is why the pharmaceutical industry has cleverly arranged things so that it says vaccine-related complications are those that occur within the first four weeks after a vaccine is given. Lawyers in the UK, the US, Germany, Australia and Canada are already preparing mass indictments, starting with the prime ministers of the respective governments and ending with the health ministers.”Dlatego właśnie przemysł farmaceutyczny sprytnie się urządził, mówiąc, że komplikacje poszczepienne to takie, które mają miejsce w ciągu pierwszych czterech tygodni od podania szczepionki. Prawnicy z Wielkiej Brytanii, USA, Niemiec, Australii oraz Kanady już przygotowują masowe akty oskarżenia, zaczynając od premierów poszczególnych rządów, kończąc na ministrach zdrowia.
Dr Astrid Stuckelberger
Dr Astrid Stuckelberger says that the WHO coordinates and supports the vaccine business together with Gavi and CEPI.
„So WHO coordinates and supports the vaccine business with Gavi and CEPI. This is the European Alliance for Innovation. And this is from the beginning of 2020. They did that already. Development, manufacturing of vaccine policy allocation procurement.”So WHO coordinates and supports the vaccine business with Gavi and CEPI. This is the European Alliance for Innovation. And this is from the beginning of 2020. They did that already. Development, manufacturing of vaccine policy allocation procurement.
Dr Astrid Stuckelberger
Dr Astrid Stuckelberger lists the pharmaceutical and vaccine industries as part of the private sector involved in the plan she describes.
„So the pharma, the vaccine industry, and by the way, it's probably all the same consortium behind, but definitely Bill Gates, who was at the head of the global vaccine plan of WHO from 2010 to 2020. I'll show you in the next slide. But, okay, I'll try to go not...”So the pharma, the vaccine industry, and by the way, it's probably all the same consortium behind, but definitely Bill Gates, who was at the head of the global vaccine plan of WHO from 2010 to 2020. I'll show you in the next slide. But, okay, I'll try to go not...
Jerzy Zięba
Jerzy Zięba points out that the manufacturer reported conditions occurring after the vaccine was brought to market, and asks why parents are not given this information.
„Even the vaccine manufacturer itself reported that, after it was used (but only after the vaccine had been released on the market), conditions such as muscle paralysis, migraines and, for example, multiple sclerosis had been reported. Why is this information not given to the children's parents?”Kiedy to nawet sam producent szczepionki informuje, że po jej zastosowaniu (ale już po wypuszczeniu szczepionki na rynek) zgłaszano schorzenia takie, jak paraliż mięśni, migreny czy np. stwardnienie rozsiane. Dlaczego nie jest to przekazywane rodzicom dzieci?
Research from PubMed · Europe PMC
We selected 2 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 3 379.
A study estimated that companies captured at most only a small share of the social value created by COVID-19 innovations.
Aim of the study: The rapid emergence of vaccines and therapeutics in response to the onset of the coronavirus (COVID-19) pandemic demonstrated the value of medical innovation. These advances not only led to enhanced patient welfare by reducing the disease's mortality and morbidity but also reduced the need for costly prevention measures, such as cuts in economic activity.
Results: These scenarios include previous assessments of the contributing subparts of the value generated by the innovations. Our primary finding is that, within the large range of these counterfactual scenarios, upper-bound measures of the proportion of value appropriated by the industry ranged from 0.2 % to 4.6 % of the value generated by the vaccine and treatment innovations. Even though these are upper bound appropriation rates, they are significantly lower than those documented for other significant health sciences innovations. This suggests that COVID-19 vaccines and treatments were remarkable, not only in their swift development but also in the considerable societal value they provided, which extended far beyond the rewards to the innovating companies.
Money for the studycompany or manufacturer · Regeneron Inc
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?YES
Type of studyother
“Not stated” does not mean nobody paid — the database does not always record it.
The Lyme disease vaccine reduced the number of new infections by nearly 80%, but the manufacturer withdrew it from the market after sales declined.
Aim of the study: People living in endemic areas acquire Lyme disease from the bite of an infected tick. This infection, when diagnosed and treated early in its course, usually responds well to antibiotic therapy.
Results: A minority of patients develops more serious disease, particularly after a delay in diagnosis or therapy, and sometimes chronic neurological, cardiac, or rheumatological manifestations. In 1998, the FDA approved a new recombinant Lyme vaccine, LYMErix, which reduced new infections in vaccinated adults by nearly 80%. Just 3 years later, the manufacturer voluntarily withdrew its product from the market amidst media coverage, fears of vaccine side-effects, and declining sales. This paper reviews these events in detail and focuses on the public communication of risks and benefits of the Lyme vaccine and important lessons learned.
Money for the studygovernment, public institutions · NICHD, NIH, HHS
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies
“Not stated” does not mean nobody paid — the database does not always record it.
Perspectives and opinion materials
The content below presents the authors’ opinions, interpretations and hypotheses. It is not treated as equal to scientific studies and systematic reviews.
Orthomolecular Medicine News Service Opinion material
„Probably the most common term used to describe prevention of epidemics is "vaccine." International agencies like WHO, sovereign governments, major foundations, pharmaceutical industry, as well as leaders in major medical institutions all appear to be focused on vaccine and vaccine only. We wish we would have a Covid-19 vaccine today. We wish we had a Covid-19 vaccine 4 months ago. But unfortunately, we didn't and we don't. The best estimate of a vaccine is at least 18-24 months away, if possible at all.”Probably the most common term used to describe prevention of epidemics is "vaccine." International agencies like WHO, sovereign governments, major foundations, pharmaceutical industry, as well as leaders in major medical institutions all appear to be focused on vaccine and vaccine only. We wish we would have a Covid-19 vaccine today. We wish we had a Covid-19 vaccine 4 months ago. But unfortunately, we didn't and we don't. The best estimate of a vaccine is at least 18-24 months away, if possible at all.
Orthomolecular Medicine News Service Opinion material
„Due to public pressure, while the CDC (Centers for Disease Control) was dragging its heels, the industry voluntarily stopped the use of Thimerosal in many vaccines. However, it is still in influenza vaccines. Since many more shots are now given, by five years of age the mercury load might still be hazardous. ALUMINUM, BABY FORMULA AND ALZHEIMER'S Another known environmental toxin, aluminum, having had a role as an adjuvant for decades, has become more widely used, and is currently added as an adjuvant in Hep A, Hep B, DT, H.”Due to public pressure, while the CDC (Centers for Disease Control) was dragging its heels, the industry voluntarily stopped the use of Thimerosal in many vaccines. However, it is still in influenza vaccines. Since many more shots are now given, by five years of age the mercury load might still be hazardous. ALUMINUM, BABY FORMULA AND ALZHEIMER'S Another known environmental toxin, aluminum, having had a role as an adjuvant for decades, has become more widely used, and is currently added as an adjuvant in Hep A, Hep B, DT, H.
Orthomolecular Medicine News Service Opinion material
„This outcome may be partially due to the US granting pharmaceutical companies immunity from litigation arising from adverse vaccine reactions.”This outcome may be partially due to the US granting pharmaceutical companies immunity from litigation arising from adverse vaccine reactions.
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.